Response rate with weekly epirubicin and docetaxel as neoadjuvant chemotherapy (NAC) for locally-advanced breast cancer (BC).

被引：0
|
作者：
Chen, SC
Chang, HK
Lin, YC
Leung, WM
Chang, JT
Cheung, YC
Hsueh, S
Lo, YF
Tsai, HP
Chen, MF
机构：
[1] Chang Gung Mem Hosp, Taipei 10591, Taiwan
[2] Breast Canc Study Grp, Taipei 10591, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：99S / 99S
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Iqbal, Javeria
    Shafi, Alam Ara
    Alharthi, Bandar N.
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (11): : 845 - 848
  • [42] Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
    Specht, Jennifer
    Gralow, Julie R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2009, 19 (04) : 222 - 228
  • [43] Neoadjuvant chemotherapy for locally advanced breast cancer
    Fomenko, Y.
    Sirota, V.
    Bitz, U.
    Zhumakaeva, S.
    Omarova, I.
    Kabildina, N.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [44] PRESURGICAL NEOADJUVANT CHEMOTHERAPY IN LOCALLY-ADVANCED BREAST-CANCER (CMLA) - PRELIMINARY-STUDY
    CARTEI, G
    MARSILIO, P
    MORANDINI, G
    ROSA, BA
    CLOCCHIATTI, L
    GALLETTI, D
    SIBAU, A
    CACCIAVILLANI, C
    CENDRON, R
    PULIN, A
    DIBELLO, B
    SABUCCO, P
    [J]. TUMORI, 1986, 72 (06) : 695 - 695
  • [45] Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective
    Schegerin, Marc
    Tosteson, Anna N. A.
    Kaufman, Peter A.
    Paulsen, Keith D.
    Pogue, Brian W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 537 - 547
  • [46] Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective
    Marc Schegerin
    Anna N. A. Tosteson
    Peter A. Kaufman
    Keith D. Paulsen
    Brian W. Pogue
    [J]. Breast Cancer Research and Treatment, 2009, 114
  • [47] Phase II study of combined docetaxel, epirubicin, and cyclophosphamide as a neoadjuvant chemotherapy regimen in patients with locally advanced breast cancer in a single institution
    Yao, X.
    Hosenpud, J. R.
    Chitambar, C. R.
    Charlson, J. A.
    Cheng, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Neoadjuvant 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer.
    Heller, W.
    Mazhar, D.
    Ward, R.
    Lowdell, C.
    Dudley, S.
    Sami, S.
    Carlo, P.
    Charles, C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S157 - S157
  • [49] Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)?
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 121 - 121
  • [50] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    [J]. JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
12345